Evidence map›Paper›PMID 25786224›Full record

ArticlePloS one2015

Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.

Eric O Johnson, Dana B Hancock, Nathan C Gaddis, Joshua L Levy, Grier Page, Scott P Novak, Cristie Glasheen, Nancy L Saccone, John P Rice, Michael P Moreau and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. SKP1-CUL1-F-box: Key molecular targets affecting disease progression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Nucleic acid testing and molecular characterization of HIV infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Eric O JohnsonRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
Dana B HancockRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
Nathan C GaddisRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
Joshua L LevyRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
Grier PageRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
Scott P NovakRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
Cristie GlasheenRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
Nancy L SacconeWashington University School of Medicine, St. Louis, MO, United States of America.
John P RiceWashington University School of Medicine, St. Louis, MO, United States of America.
Michael P MoreauRutgers University Cell and DNA Repository (RUCDR), Piscataway, NJ, United States of America.
Kimberly F DohenyCenter for Inherited Disease Research (CIDR), Johns Hopkins University, Baltimore, MD, United States of America.
Jane M RommCenter for Inherited Disease Research (CIDR), Johns Hopkins University, Baltimore, MD, United States of America.
Andrew I BrooksRutgers University Cell and DNA Repository (RUCDR), Piscataway, NJ, United States of America.
Bradley E AouizeratSchool of Nursing, University of California San Francisco, San Francisco, CA, United States of America; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, United States of America.
Laura J BierutWashington University School of Medicine, St. Louis, MO, United States of America.
Alex H KralRTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America.
RTI International · USWashington University in St. Louis · USJohns Hopkins University · USRutgers, The State University of New Jersey · USUniversity of California, San Francisco · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION, MANAGEMENT AND COMMUNICATIONSU01AI034989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, GREENBLATT, RUTH MARTHA · 1993 to 2018
$65.6M
Women's Interagency HIV Study (WIHS) IIIU01AI031834 · NIAID · SUNY DOWNSTATE MEDICAL CENTER · PI GUSTAFSON, DEBORAH R., MINKOFF, HOWARD · 1998 to 2018
$53.5M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) ORGANIZATION AND MANAGEMENTU01AI034994 · NIAID · GEORGETOWN UNIVERSITY · PI KASSAYE, SEBLE G · 1993 to 2018
$52.0M
Women's Interagency HIV Study (WIHS) IV, Chicago ConsortiumU01AI034993 · NIAID · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI COHEN, MARDGE H, FRENCH, AUDREY · 1994 to 2018
$51.0M
WOMENS INTERAGENCY HIV STUDY (WIHS)U01HD032632 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MILAM, JOEL E · 1994 to 2012
$42.0M
WIHS DATA MANAGEMENT AND ANALYSIS CENTER(WDMAC)U01AI042590 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GANGE, STEPHEN J, GOLUB, ELIZABETH T · 1998 to 2018
$38.4M
Enhancing Discovery of HIV Host Genetics using Drug Abuse and other InteractionsR01DA038632 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI JOHNSON, ERIC OTTO · 2014 to 2018
$3.7M
Genome-Wide Association Study of HIV-1 Host Genetics Among Injection Drug UsersR01DA026141 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI JOHNSON, ERIC OTTO · 2008 to 2012
$3.5M
NCRR NIH HHS UL1 RR024131NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS X01 HG005275NHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INIAID NIH HHS AI034989-S17NIAID NIH HHS U01 AI031834NIAID NIH HHS U01 AI034989NIAID NIH HHS U01 AI034993NIAID NIH HHS U01 AI034994NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI042590NIAID NIH HHS U01-AI-31834NIAID NIH HHS U01-AI-34989NIAID NIH HHS U01-AI-34993NIAID NIH HHS U01-AI-34994NIAID NIH HHS U01-AI-35004NIAID NIH HHS U01-AI-42590NICHD NIH HHS 0-HD-32632NICHD NIH HHS U01 HD032632NIDA NIH HHS N01DA-09-7770NIDA NIH HHS R01 DA026141NIDA NIH HHS R01 DA038632
6 · The paper itself

Abstract

Fifty percent of variability in HIV-1 susceptibility is attributable to host genetics. Thus identifying genetic associations is essential to understanding pathogenesis of HIV-1 and important for targeting drug development. To date, however, CCR5 remains the only gene conclusively associated with HIV acquisition. To identify novel host genetic determinants of HIV-1 acquisition, we conducted a genome-wide association study among a high-risk sample of 3,136 injection drug users (IDUs) from the Urban Health Study (UHS). In addition to being IDUs, HIV-controls were frequency-matched to cases on environmental exposures to enhance detection of genetic effects. We tested independent replication in the Women's Interagency HIV Study (N=2,533). We also examined publicly available gene expression data to link SNPs associated with HIV acquisition to known mechanisms affecting HIV replication/infectivity. Analysis of the UHS nominated eight genetic regions for replication testing. SNP rs4878712 in FRMPD1 met multiple testing correction for independent replication (P=1.38x10(-4)), although the UHS-WIHS meta-analysis p-value did not reach genome-wide significance (P=4.47x10(-7) vs. P<5.0x10(-8)) Gene expression analyses provided promising biological support for the protective G allele at rs4878712 lowering risk of HIV: (1) the G allele was associated with reduced expression of FBXO10 (r=-0.49, P=6.9x10(-5)); (2) FBXO10 is a component of the Skp1-Cul1-F-box protein E3 ubiquitin ligase complex that targets Bcl-2 protein for degradation; (3) lower FBXO10 expression was associated with higher BCL2 expression (r=-0.49, P=8x10(-5)); (4) higher basal levels of Bcl-2 are known to reduce HIV replication and infectivity in human and animal in vitro studies. These results suggest new potential biological pathways by which host genetics affect susceptibility to HIV upon exposure for follow-up in subsequent studies.

Indexed as

Genetic LociGenetic Predisposition to DiseaseVirus ReplicationCarrier ProteinsCross-Sectional StudiesF-Box ProteinsFemaleGene ExpressionGenome-Wide Association StudyHIV-1HIV InfectionsHumansMalePolymorphism, Single NucleotideProto-Oncogene Proteins c-bcl-2Ubiquitin-Protein LigasesBCL2 protein, humanCarrier ProteinsF-Box ProteinsFBXO10 protein, humanFrmpd1 protein, humanProto-Oncogene Proteins c-bcl-2Ubiquitin-Protein Ligases

Identifiers

PMID25786224
PMCPMC4364715
OpenAlexW2084650334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.